Literature DB >> 15009042

Development of malignant breast microcalcifications after neoadjuvant chemotherapy in advanced breast cancer.

Dalia Fadul1, Jocelyn Rapelyea, Arnold M Schwartz, Rachel F Brem.   

Abstract

The increased interest in the use of neoadjuvant chemotherapy for patients with locally advanced or large tumors at initial presentation necessitates the recognition of sequelae of this therapy. This article describes the interval appearance of malignant, linear-branching, microcalcifications during neoadjuvant chemotherapy for locally advanced breast cancer. Mammographically the malignant microcalcifications appeared only in the region of the breast where the primary tumor was found. Pathologically only a subpopulation of malignant cells responded to the chemotherapy, demonstrating viability of the majority of the tumor, with cell death only in the subpopulation. With the increased use of neoadjuvant chemotherapy, it is important to recognize previously undescribed mammographic findings secondary to this therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009042     DOI: 10.1111/j.1075-122x.2004.21365.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  5 in total

1.  Pathologic Complete Response of HER-2 Neu-Positive Invasive Ductal Carcinoma and Ductal Carcinoma In Situ following Neoadjuvant Chemotherapy plus Trastuzumab: A Case Report and Review of Literature.

Authors:  Sommer R Gunia; Mita S Patel; Eleftherios P Mamounas
Journal:  Case Rep Surg       Date:  2012-01-19

2.  Increased Malignant Microcalcifications after Neoadjuvant Chemotherapy in Advanced Breast Cancer.

Authors:  Gi Won Shin; Young Mi Park; Hye Kyoung Yoon; Soo Jin Jung; Tae Hyun Kim; Anbok Lee; Seok Mo Lee
Journal:  J Breast Cancer       Date:  2016-12-23       Impact factor: 3.588

3.  The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluation.

Authors:  Jun-jie Li; Canming Chen; Yajia Gu; Genhong Di; Jiong Wu; Guangyu Liu; ZhiMin Shao
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

Review 4.  Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials.

Authors:  Raquel F D van la Parra; Henry M Kuerer
Journal:  Breast Cancer Res       Date:  2016-03-08       Impact factor: 6.466

5.  Is Breast Surgery Necessary for Breast Carcinoma in Complete Remission Following Neoadjuvant Chemotherapy?

Authors:  Hannah Richter; André Hennigs; Benedikt Schaefgen; Markus Hahn; Jens Uwe Blohmer; Sherko Kümmel; Thorsten Kühn; Marc Thill; Kay Friedrichs; Christof Sohn; Michael Golatta; Jörg Heil
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-01-22       Impact factor: 2.915

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.